217: Evaluation of single-dose palifermin to reduce mucositis: Assessment of efficacy and safety in patients (PTS) with hematologic malignancies (HM) receiving autologous peripheral blood progenitor cell (PBPC) transplantation
T. Shea, T. Kewalramani, Y. Mun, J. Jayne, L. DreilingVolume:
13
Year:
2007
Language:
english
Pages:
81
DOI:
10.1016/j.bbmt.2006.12.221
File:
PDF, 70 KB
english, 2007